http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201331163-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_442006254efb98c9cebec6ee5a08d5e8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-65 |
| filingDate | 2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2a8c454fe3f376c53f027918405789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9100ea8191c7df70a0977165d6a6a89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad352771e22cd6f303d3472174918353 |
| publicationDate | 2013-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201331163-A |
| titleOfInvention | Medicine composition for inhibiting, treating lung tumor and inhibiting inflammatory reaction and preparation method thereof |
| abstract | The pharmaceutical composition for inhibiting, treating, and inhibiting an inflammatory reaction of the present invention comprises an inhibitor comprising a peroxisome proliferator-activated receptor γ as an active ingredient thereof, and having the same as a therapeutic or inhibiting human Non-small cell lung cancer, or a pharmaceutical use for inhibiting an inflammatory response associated with human non-small cell lung cancer, specifically, a pharmaceutical composition such as Lopac, which is currently widely used for the treatment of type 2 diabetes. GW9662 is an active ingredient thereof, and specifically, the active ingredient is a compound of 2-chloro-5-nitro-N-phenylbenzamide (C13H9N2O3Cl, 2-Chloro-5-nitro-N-phenyl-benzamide). |
| priorityDate | 2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.